We use cookies to help provide you with the best possible online experience. Learn more

    RaySearch receives first order for the RayCare™ Oncology infomation System

    PDF

    Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, USA, has placed the first order for RayCare*, a next-generation oncology information system (OIS). RayCare is an innovative system designed to support comprehensive cancer care. It integrates seamlessly with the RayStation treatment planning system, but that’s just the start – RayCare will connect all the oncology disciplines, enabling users to fluidly coordinate tasks and ensure optimal use of resources.

    Over subsequent releases, RayCare will evolve into a machine learning OIS with unique capabilities to coordinate oncology tasks, supporting comprehensive cancer care organized around each patient’s needs. Many cancer patients receive a combination of treatment types, driving the need for combined workflows for radiation therapy, chemotherapy and surgery.

    ARCC decided to map out a future for their clinical workflows that would support advanced technology and data driven decision making. They determined that the best approach would be to move to a new treatment planning system and a new oncology information system that together would support their linacs and TomoTherapy systems, in order to have a unified platform for planning, treatment and assessment.

    Paul King, Chief Medical Physicist, says: “We evaluated all the leading systems and were extremely impressed by the possibilities of RayCare. It delivers on everything we were looking for. Getting all of these pieces integrated together will help us tremendously. RaySearch is an innovator with the leading technology in this area and I have great confidence in their ability to meet our needs into the future. We will keep exploring the cutting-edge of technology in order to secure the best possible care for our patients. RayCare will help us achieve this aim.”

    Dr. Scott Anderson, Radiation Oncologist and Medical Director, says: “We find ourselves in the position that we are at a decision point where we can stay static in a satisfactory status quo, or we can move into what will be the standard in the future. We look forward to working with RaySearch Laboratories to shape the future of longitudinal cancer care. Survivorship and tracking patients long term will be the benchmarks of cancer care moving forward. This new system that is being developed will give us better tools to do so.”

    Johan Löf, CEO of RaySearch, says: “I am delighted by this first RayCare order and very excited about helping ARCC achieve an efficient, integrated system for the future. RayCare is fundamentally different compared to other OIS systems, and we have invested a great deal of time and effort into creating something that will truly change the way that cancer is treated. Our goal is to advance cancer treatment with high-performance tools that combine treatment planning, workflow and data management, resource optimization, machine learning and follow-up in an effective way.”

    About Anderson Regional Cancer Center
    Anderson Regional Cancer Center in Meridian, Mississippi, is a state-of-the-art cancer center equipped to provide innovative treatment for all types of cancer. The center sees about 180 outpatients a day for radiation or chemotherapy treatments and serves a geographical area across East Mississippi and West Alabama.

    About RayCare
    RayCare represents the future of OIS technology, developed from the ground up by RaySearch to support the complex logistical challenges of modern, large-scale radiation therapy centers. RayCare will integrate the high-performance radiation therapy algorithms available in RayStation with advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.

    About RaySearch
    RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company has now launched the next-generation oncology information system, RayCare*, which comprises a new product area for RaySearch. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.


    To learn more about RaySearch, go to:
    www.raysearchlabs.com

    * Subject to regulatory clearance in some markets.

    For further information, please contact:
    Johan Löf, President and CEO, RaySearch Laboratories AB (publ)

    Telephone: +46 (0)8-510 530 00
    johan.lof@raysearchlabs.com
     

    PDF

    RayStation selected for new Carbon ion therapy center in Japan

    PDF

    RayStation* has been chosen as the treatment planning system for a new carbon-ion therapy facility which is under construction at Yamagata University Hospital in northern Japan. The order represents the first RayStation carbon ion installation in Japan.

    Carbon ion therapy is an advanced form of radiation therapy that precisely targets cancer cells with minimal damage to surrounding tissue. The technique uses a carbon ion beam, accelerated up to 70% of the speed of light. Carbon ion beams are highly effective in destroying cancer cells, and the technique can be effective for cancers that are resistant to X-rays. An additional advantage is that the treatment period often is shorter than for other forms of radiation therapy.

    RayStation was selected jointly by Yamagata University Hospital and Toshiba, which is supplying the treatment delivery system. The decision was motivated by RayStation’s outstanding functionality and comprehensive support for this cutting-edge treatment technique. The RayStation installation will include modules for carbon pencil beam scanning with robust biological optimization (using both the MKM and LEM models), deformable registration, dose tracking and adaptive therapy.

    The facility expects to treat its first patients by early 2020. Toshiba’s treatment delivery system will comprise two treatment rooms, a fixed-port room and a 360-degree rotating compact superconducting gantry. The facility will be the most compact carbon ion installation in the world, and one of the few integrated into a general hospital.

    Johan Löf, CEO of RaySearch, says: “RaySearch is committed to providing the leading support for cutting-edge techniques such as carbon ion therapy, and we are very pleased to meet the needs of Yamagata University Hospital and Toshiba. RayStation has a strong and growing user base in Japan, and we will continue to focus resources on this technologically advanced market.”
      

    About Yamagata University Hospital
    Yamagata University Hospital is a major general hospital located in Yamagata prefecture, northern Japan. Established in 1976, the hospital offers a wide range of medical specialties, including oncology. The hospital’s clinical cancer center was established in 2007. Yamagata University Hospital works to pursue its philosophy of “deeply humane and reliable medical care.”

    About RayStation
    RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy*. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.

    About RaySearch
    RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company recently launched the next-generation oncology information system, RayCare*, which comprises a new product area for RaySearch. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since November 2003.

    To learn more about RaySearch, go to: www.raysearchlabs.com

    * Subject to regulatory clearance in some markets.
     

    For further information, please contact:
    Johan Löf, President and CEO, RaySearch Laboratories AB (publ)

    Telephone: +46 (0)8-510 530 00

    johan.lof@raysearchlabs.com

    PDF